Combining an antiplatelet with oral anticoagulants in stroke patients with AF and cardiovascular disease slightly lowers ...

Further results from the MASTER DAPT trial of abbreviated dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients at high bleeding risk stratified by use of oral ...

Please provide your email address to receive an email when new articles are posted on . Direct oral anticoagulation in patients not previously indicated for it who underwent transcatheter aortic valve ...

Adding an anticoagulant to antiplatelet therapy for peripheral arterial disease (PAD) does little practical good while at the same time more than tripling the risk of dangerous bleeding, according to ...

Researchers have found in a new study that in patients with nonvalvular atrial fibrillation (AF) and atherosclerosis, the addition of antiplatelet therapy to anticoagulants did not reduce ...

Please provide your email address to receive an email when new articles are posted on . Risk for stroke after cervical artery dissection was similar with an anticoagulation vs. antiplatelet treatment ...

CHICAGO, IL—Data from a new study provide yet more support for the use of single antiplatelet therapy (SAPT) after TAVI, with investigators concluding that dual antiplatelet therapy (DAPT) should be ...

The Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis (ATIS-NVAF) trial included 316 patients from 41 centers in Japan. Mean age was 77.2 ...

Researchers have found in a new study that among patients undergoing valve-in-valve transcatheter aortic procedures, ...

BARCELONA, Spain—New results from three trials presented here at the European Society of Cardiology Congress 2022 have provided additional insights into what works—and what doesn’t—for addressing the ...